Want to join the conversation?
$LXU said turnaround activities and various operational issues resulted in unplanned downtime at its 3 primary chemical facilities during 3Q16. The company expects the combined impact to 3Q16 EBITDA as a result of reduced production, lost fixed cost absorption and repair expenses related to unplanned maintenance to be $25-26.5MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.